Solve M.E. CEO Emily Taylor Featured in LA Weekly for Advancing Breakthrough Research
Our CEO, Emily Taylor, is featured in LA Weekly for her leadership in shaping the
May 14, 2026
Our CEO, Emily Taylor, is featured in LA Weekly for her leadership in shaping the
In recognition of World ME Day, Solve M.E. announced today new funding for two award-winning
Dr. Liisa Selin, Dr. Ayano Kohlgruber, and Dr. Roshan Kumar received a Solve ME/CFS Catalyst
When an organization, like a government agency, company, or nonprofit, considers a big change or
Glucagon-Like Peptide-1 (GLP-1) agonist medications, like semaglutide, are injectable or oral drugs that mimic the
In our “What’s New in ME/CFS?” series, we spotlight researchers transforming what we can do
Solve M.E. is proud to support two pioneering studies through our latest round of ME/CFS
Dear Friends, As this year comes to a close, I find myself thinking not just
Dr. Akiko Iwasaki, Sterling Professor of Immunology at Yale University and winner of the 2025